Correlation Between Aquestive Therapeutics and Bausch Health

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aquestive Therapeutics and Bausch Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aquestive Therapeutics and Bausch Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aquestive Therapeutics and Bausch Health Companies, you can compare the effects of market volatilities on Aquestive Therapeutics and Bausch Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aquestive Therapeutics with a short position of Bausch Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aquestive Therapeutics and Bausch Health.

Diversification Opportunities for Aquestive Therapeutics and Bausch Health

0.57
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Aquestive and Bausch is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Aquestive Therapeutics and Bausch Health Companies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bausch Health Companies and Aquestive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aquestive Therapeutics are associated (or correlated) with Bausch Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bausch Health Companies has no effect on the direction of Aquestive Therapeutics i.e., Aquestive Therapeutics and Bausch Health go up and down completely randomly.

Pair Corralation between Aquestive Therapeutics and Bausch Health

Given the investment horizon of 90 days Aquestive Therapeutics is expected to generate 2.01 times more return on investment than Bausch Health. However, Aquestive Therapeutics is 2.01 times more volatile than Bausch Health Companies. It trades about -0.06 of its potential returns per unit of risk. Bausch Health Companies is currently generating about -0.31 per unit of risk. If you would invest  552.00  in Aquestive Therapeutics on September 2, 2024 and sell it today you would lose (43.00) from holding Aquestive Therapeutics or give up 7.79% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Aquestive Therapeutics  vs.  Bausch Health Companies

 Performance 
       Timeline  
Aquestive Therapeutics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Aquestive Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, Aquestive Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
Bausch Health Companies 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Bausch Health Companies are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak technical indicators, Bausch Health exhibited solid returns over the last few months and may actually be approaching a breakup point.

Aquestive Therapeutics and Bausch Health Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aquestive Therapeutics and Bausch Health

The main advantage of trading using opposite Aquestive Therapeutics and Bausch Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aquestive Therapeutics position performs unexpectedly, Bausch Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bausch Health will offset losses from the drop in Bausch Health's long position.
The idea behind Aquestive Therapeutics and Bausch Health Companies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Equity Valuation
Check real value of public entities based on technical and fundamental data
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope